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Campylobacter is the cause of the majority of intestinal disease in humans. It is present in the 
gastro-intestinal tract of many poultry and it is therefore very difficult to prevent this pathogen from 
persisting on derived products. Recent restrictions on the use of antibiotics as growth promoters in 
animal production have added to this problem. Bacteriophage (phage) therapy is a promising 
alternative method of controlling this pathogen. In this study the in vitro and in vivo performance of 3 
Campylobacter phages were tested. The phages were selected from a panel of 47 isolated from 
poultry intestines based on their wide lytic spectra and ability to lyse strains of Campylobacter coli and 
Campylobacter jejuni. The 3 phages were identified, by Transmission Electron Microscopy (TEM), as 
members of the family Myoviridae and their burst size and latent period were determined. In vivo tests 
in poultry infected with Campylobacter coli and Campylobacter jejuni showed that the phages reduced 
these pathogens by 1-2 log10 CFU/g. There was no significant difference in the performances of the 3 
phages either individually or as a cocktail. Our findings are that these phages could be used to control 
Campylobacter in infected poultry. 
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